Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00458978Phase 2Completed
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Chandylen Nightingale

Wake Forest University Health Sciences

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Hassan Arshad

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Siddharth Sheth

Alliance for Clinical Trials in Oncology

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Jacob S Thomas

City of Hope Comprehensive Cancer Center LAO

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Nicole C Schmitt, MD, FACS

Emory University Hospital/Winship Cancer Institute

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Cristina Rodriguez

Fred Hutch/University of Washington Cancer Consortium

Related
2 trials

Shared therapeutic areas:

Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Salivary Gland CarcinomaSquamous Cell Carcinoma Metastatic in the Neck With Occult Primary

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Stage IV Hypopharyngeal Squamous Cell CarcinomaStage IV Laryngeal Squamous Cell CarcinomaStage IV Oropharyngeal Squamous Cell Carcinoma
Similarity Score4%

Marcelo R Bonomi, MD

Ohio State University Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma
Similarity Score4%

Aarti Bhatia

ECOG-ACRIN Cancer Research Group

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00458978Phase 2PrincipalInvestigator

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
Completed

All 1 trials loaded